Institutional investors purchased a net $1.0 million shares of ICPT during the quarter ended March 2018. This may signal that the smart money is gaining interest in this company as the 71.58% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SARISSA CAPITAL MANAGEMENT LP Bought 453.0 Thousand shares of Intercept Pharmaceuticals...
ELK CREEK PARTNERS LLC Bought 348.5 Thousand shares of Intercept Pharmaceuticals...